Literature DB >> 17125970

Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population.

Eduardo Domínguez1, María Isabel Loza, Fernando Padín, Alejandro Gesteira, Eduardo Paz, Mario Páramo, Julio Brenlla, Estefanía Pumar, Fernanda Iglesias, Alcira Cibeira, Marián Castro, Héctor Caruncho, Angel Carracedo, Javier Costas.   

Abstract

The serotonin and dopamine neurotransmitter systems are candidate pathways in the development of schizophrenia because of the assumed causal relationship with the observed symptoms as well as effective targeting of the corresponding receptors by antipsychotic drugs. However, genetic association studies have systematically focused on a limited set of genes and single nucleotide polymorphisms (SNPs), including T102C at HTR2A and Ser9Gly at DRD3. Meta-analyses of the associations between these two markers and schizophrenia revealed a true increase in risk, the magnitude of the effect being very low. In the present study we analyzed 260 schizophrenic patients and 354 control subjects from a homogeneous population, the Galician population, using an extensive linkage disequilibrium (LD) mapping approach, genotyping a total of 47 SNPs to test for the existence of additional variants that confer higher risk. We detected nominal significant association with schizophrenia for several haplotype tag SNPs (htSNPs) at HTR2A, although the significance was lost after multiple test corrections. In addition, haplotype analyses involving a sliding window approach, with window size 2 to 4 SNPs, revealed significant differences in frequencies of the DRD3 haplotypes at the 3' half of the gene region. This difference, which remains clearly significant after multiple test corrections (p=0.002, 0.0001, and 0.0025, for window sizes 2, 3, and 4, respectively), was mainly due to over-representation of several rare haplotypes in patients, at the expense of a single common haplotype; this represents interesting evidence of rare haplotypes for susceptibility detected using common htSNPs due to their strong effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125970     DOI: 10.1016/j.schres.2006.09.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

1.  The dopamine D3 receptor gene and posttraumatic stress disorder.

Authors:  Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Alison Aiello; Sandro Galea; Karestan C Koenen; Monica Uddin; Derek Wildman; Mark W Miller
Journal:  J Trauma Stress       Date:  2014-08

2.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

3.  A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia.

Authors:  Javier Costas; Noa Carrera; Eduardo Domínguez; Elisabet Vilella; Lourdes Martorell; Joaquín Valero; Alfonso Gutiérrez-Zotes; Antonio Labad; Angel Carracedo
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

4.  Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

Authors:  Prachi Kukshal; Venkat Chowdari Kodavali; Vibhuti Srivastava; Joel Wood; Lora McClain; Triptish Bhatia; A M Bhagwat; Smita Neelkanth Deshpande; Vishwajit Laxmikant Nimgaonkar; B K Thelma
Journal:  J Psychiatr Res       Date:  2013-08-08       Impact factor: 4.791

5.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

Review 6.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

7.  Association analysis of 94 candidate genes and schizophrenia-related endophenotypes.

Authors:  Tiffany A Greenwood; Gregory A Light; Neal R Swerdlow; Allen D Radant; David L Braff
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

8.  Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.

Authors:  Harpreet Kaur; Ajay Jajodia; Sandeep Grover; Ruchi Baghel; Meenal Gupta; Sanjeev Jain; Ritushree Kukreti
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  Machine learning techniques for single nucleotide polymorphism--disease classification models in schizophrenia.

Authors:  Vanessa Aguiar-Pulido; José A Seoane; Juan R Rabuñal; Julián Dorado; Alejandro Pazos; Cristian R Munteanu
Journal:  Molecules       Date:  2010-07-12       Impact factor: 4.411

10.  Regulatory Role of lncRNA NONHSAT089447 in the Dopamine Signaling Pathway in Schizophrenic Patients.

Authors:  Shengdong Chen; Xiaoli Zhu; Wei Niu; Gaofeng Yao; Lingming Kong; Mingjun He; Chunxia Chen; Zhengbin Lu; Xuelian Cui; Liyi Zhang
Journal:  Med Sci Monit       Date:  2019-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.